GASOLINERA AGULLENT
1.0
Copermática S.L.
0.00
0 reviews
Free
About GASOLINERA AGULLENT
GASOLINERA AGULLENT is an app developed
by Copermática S.L..
The app has been available since 1 day ago.
It's highly ranked.
The app has no ratings yet. The last update of the app was on September 1, 2025. GASOLINERA AGULLENT has a content rating "Everyone".
GASOLINERA AGULLENT has an download size of 61.38 MB and the latest version available is 1.0. GASOLINERA AGULLENT is FREE to download.
It's highly ranked.
The app has no ratings yet. The last update of the app was on September 1, 2025. GASOLINERA AGULLENT has a content rating "Everyone".
GASOLINERA AGULLENT has an download size of 61.38 MB and the latest version available is 1.0. GASOLINERA AGULLENT is FREE to download.
Description
More data about GASOLINERA AGULLENT
| Price | Free to download |
| Rating | No ratings |
| Ranking | Highly ranked |
| Version | 1.0 |
| App download size | 61.4 MB |
| Suitable for | Everyone |
More from Copermática S.L.
Changelog
No changelog data
Developer information for Copermática S.L.
Copermática S.L.
N/A
Share
Comments on GASOLINERA AGULLENT for iOS
We don't have enough comments to show example comments. Please check back later.
App Store Rankings
Top rankings
| Rank | Country | Category | List |
|---|---|---|---|
| 75 | United States | Books | New Apps |
| 75 | United States | Business | New Apps |
| 75 | United States | Education | New Apps |
| 75 | United States | Entertainment | New Apps |
| 75 | United States | Finance | New Apps |
| 75 | United States | Food & Drink | New Apps |
| 75 | United States | Games | New Apps |
| 75 | United States | Action Games | New Apps |
| 75 | United States | Adventure Games | New Apps |
| 75 | United States | Arcade Games | New Apps |
Ranking history in United States
AppBrain offers valuable information about your app and those of your competitors. Join AppBrain for free and claim this app to view more ranking data, view history etc.
I'm the developer of this app
Technologies used by GASOLINERA AGULLENT
Back to top